> Details

Comi, Giancarlo; Bermel, Robert; Bar-Or, Amit; McGinley, Marisa; Arnold, Douglas; Henry, Roland; Benedict, Ralph; Bhargava, Pavan; Butzkueven, Helmut; Chard, Declan; Gherardi, Guy; Howell, Owain; Lebrun-Frenay, Christine; Leocani, Letizia; Kazlauskaite, Agne; Kuenzel, Thomas; Montalban, Xavier; Sormani, Maria Pia; Sellebjerg, Finn; Craveiro, Licinio; Lubetzki, Catherine

A multicentre, open label, single-arm, phase 3b study (CONSONANCE) to assess the effectiveness and safety of ocrelizumab in patients with primary and secondary progressive multiple sclerosis: year-1 interim analysis (P1-1.Virtual)

Reference
management

Bookmarks

Remove from
bookmarks

Share this on Whatsapp

Close

Bookmarks



You can manage bookmarks using lists, please log in to your user account for this.
  • Media type: E-Article
  • Title: A multicentre, open label, single-arm, phase 3b study (CONSONANCE) to assess the effectiveness and safety of ocrelizumab in patients with primary and secondary progressive multiple sclerosis: year-1 interim analysis (P1-1.Virtual)
  • Contributor: Comi, Giancarlo; Bermel, Robert; Bar-Or, Amit; McGinley, Marisa; Arnold, Douglas; Henry, Roland; Benedict, Ralph; Bhargava, Pavan; Butzkueven, Helmut; Chard, Declan; Gherardi, Guy; Howell, Owain; Lebrun-Frenay, Christine; Leocani, Letizia; Kazlauskaite, Agne; Kuenzel, Thomas; Montalban, Xavier; Sormani, Maria Pia; Sellebjerg, Finn; Craveiro, Licinio; Lubetzki, Catherine
  • imprint: Ovid Technologies (Wolters Kluwer Health), 2022
  • Published in: Neurology
  • Language: English
  • DOI: 10.1212/wnl.98.18_supplement.652
  • ISSN: 1526-632X; 0028-3878
  • Origination:
  • Footnote: